-
Genomic and transcriptomic landscape of T-cell lymphoblastic lymphoma compared to T-cell acute lymphoblastic leukemia: similar subtypes and different fusions
Study
EGAS00001007767
-
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Study
EGAS00001007873
-
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Study
EGAS00001007911
-
Ewing and Ewing-like-sarcoma tumoroid biobank reveals distinct drug sensitivities: translocation makes the difference
Study
EGAS00001007941
-
Preclinical Pediatric Molecular Analysis for Therapy Choice (MATCH)
Study
EGAS00001008011
-
Three-dimensional patient-derived models of glioblastoma retain intra-tumoral heterogeneity
Study
EGAS00001008023
-
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target
Study
EGAS00001008039
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_ATAC
Study
EGAS00001008083
-
Segmental_cherry_angioma_case
Study
EGAS00001008212
-
Cross-species Comparison Reveals Therapeutic Vulnerabilities Halting Glioblastoma Progression
Study
EGAS00001008155
-
Molecular characterisation of paediatric PDX cells before and after 3D RASTRUM bioprintin
Study
EGAS00001008220
-
Whole exome sequencing data for paired non-serous endometrial and ovarian carcinomas from 27 patients with concurrent tumours.
Study
EGAS00001008259
-
Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
Study
EGAS00001007002
-
Molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (N2M2/NOA-20 phase I/IIa umbrella trial)
Study
EGAS00001008033
-
Integrative Multi-Omics and Drug Sensitivity Profiling Reveals Potential Predictive Biomarkers in Pediatric Solid Tumors from the INFORM Registry
Study
EGAS00001008249
-
IMMUcan Upstream SCCHN3 cohort
Study
EGAS50000001505
-
RNAseq of organoid and fibroblast co-cultures
Dataset
EGAD50000002202
-
A benchmark of DNA methylation deconvolution methods for tumoral fraction estimation using DecoNFlow
Study
EGAS50000001529
-
Neuroblastoma cell-lines and healthy cfDNA used for the benchmarking study
Dataset
EGAD50000002199
-
DAC for study CMMRD–associated high-grade glioma
Dac
EGAC50000000855
-
Immune activation in the tumor microenvironment of renal cell carcinoma
Study
EGAS50000001349
-
scRNA transcriptome and TCR sequencing data modeling treatment responses in eight renal cell carcinoma patient
Dataset
EGAD50000001934
-
Chromosomal instability shapes the tumor microenvironment of oesophageal adenocarcinoma via a cGAS–chemokine–myeloid axis
Study
EGAS50000001561
-
Comprehensive molecular profiling identifies novel genetic drivers and subtypes underlying medulloblastoma
Study
EGAS00001001953
-
Relapse CHL study
Study
EGAS00001008222
-
Genetic landscape of pediatric ependymoma
Study
EGAS00001000254
-
Whole genome and RNA sequencing of paediatric glioblastoma in the ICGC PedBrain project
Study
EGAS00001001139
-
Whole-genome sequencing analysis of low-grade astrocytomas within the ICGC PedBrain Tumor Project
Study
EGAS00001000381
-
Genetic landscape of pediatric Medulloblastoma
Study
EGAS00001000347
-
Comprehensive genomic profiling of matched glioblastoma tumours, cell-lines, and xenografts reveals genomic stability and adaptation to disparate growth environments
Study
EGAS00001002709
-
Association of Age at Diagnosis and Genetic Mutations in Patients with Neuroblastoma
Study
EGAS00001000213
-
Genetic landscape of pediatric Rhabdomyosarcoma
Study
EGAS00001000256
-
Genetic landscape of pediatric Osteosarcoma
Study
EGAS00001000263
-
Identifying mutations in patient-derived melanoma DCC lines
Study
EGAS50000001225
-
SHH medulloblastoma samples
Study
EGAS00001000607
-
Dynamics of checkpoint receptors in γδ T cell subsets are associated with clinical responses during anti-PD-1 immunotherapies
Study
EGAS50000001270
-
Multiple myeloma treated with T-cell redirecting immunotherapies
Study
EGAS50000000546
-
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors
Study
EGAS00001000906
-
Genetic landscape of pediatric Retinoblastoma
Study
EGAS00001000346
-
Evolutionary Genome Analysis of Transformation into Small Cell Carcinomas from Lung Adenocarcinomas
Study
EGAS00001001757
-
Proteomic Characterization of Intrahepatic Cholangiocarcinoma Identifies Risk-Stratifying Subgroups, Proteins Associated with Time-To-Recurrence, and mTOR Effector Molecule EIF4A1 as a Druggable Therapeutic Target
Study
EGAS50000001343
-
Whole-exome sequencing of intrahepatic cholangiocarcinoma tumors with matched normal tissue from the Medical Center – University of Freiburg
Dataset
EGAD50000001926
-
RNAseq of 704 patients with soft tissue tumors
Dataset
EGAD50000002120
-
The genomic landscape of lung adenocarcinoma in East Asians
Study
EGAS00001002941
-
Osteosarcoma_Whole_Genome
Study
EGAS00001000147
-
Identification of gene mutations and fusion genes in patients with Sézary Syndrome
Study
EGAS00001001706
-
Prognostic relevance of microenvironmental factors CD163 and CD8 combined with EZH2 and chromosome 18 gain in a validation cohort of follicular lymphoma patients of the Lunenburg Lymphoma Biomarker Consortium
Study
EGAS00001002049
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Study
EGAS00001003931